1Brechignac S,Hellstrom-Lindberg E,Bowen DT,et al.Quality of life and economic impact of red blood cell(RBC)transfusions on patients with myelodysplastic syndromes(MDS)[J].Blood (ASH Annual Meeting Abstracts),2004,104:Abstract 4716.
3Mahesh S,Ginzburg Y,Verma A,et al.Iron overload in myelodysplastic syndromes[J].Leuk Lymphoma,2008,49(3):427-438.
4Lee JW.Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia:a review of experience in South Korea[J].Int J Hematol,2008,88:16-23.
5Di Tucci AA,Matta G,Deplano S,et al.Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias[J].Haematologica,2008,93(9):1385-1388.
6Malcovati L,Porta MG,Pascutto C,et al.Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria:a basis for clinical decision making.J Clin Oncol,2005,23:7594-7603.
7Takatoku M,Uchiyama T,Okamoto S,et al.Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights negative impact of iron overload on morbidity/mortalily[J].Eur J Haematol,2007,78(6):487-494.
8Arlnand P,Kim HT,Cutler CS,et al.Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation[J].Blood,2007,109(10):4586-4588.
9Porter J,Galanello R,Saglio G,et al.Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox(ICL670):a l-yr prospective study[J].Eur J Haernatol,2008,80(2):168-176.
10Rose C,Brechignac S,Vassilief D,et al.Positive impact of iron chelation therapy(CT)on survival in regularly transfused MDS patients.A prospective analysis by the GFM[J].Blood,2007,110:249.
2Jaffe ES,Harris NL,Stein H,et al.Pathology and genetics of tumours of haematopoietic and lymphoid tissues.Lyon:IARC Press,2001.
3Intragumtornchai T,Prayoonwiwat W,Swasdikul D,et al.Myelodysplastic syndromes in Thailand:a retrospective pathologic and clinical analysis of 117 cases.Leuk Res,1998,22:453-460.
4Matsuda A,Germing U,Jinnai I,et al.Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.Blood,2005,106:2633-2640.
5Nosslinger T,Regina R,Koller E,et al.Myelodysplastic syndrome,from French-American-British to World Health Organization:comparison of classifications on 431 unselected patients from a single institution.Blood,2001,98:2935-2941.
